Sign in
4

Changes in Ownership

Editas Medicine, Inc. Filed Acc 0001179110-18-008837

Chief Technology Officer sold 14,000 shares at an average $38.26 ($535,572)

  • Chief Technology Officer acquired 14,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Myer Vickesh · Chief Technology Officer

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2018-06-18 Exercise or conversion : show line 1 in the form +4,300 $0.65 $2,795 4,300 D
2018-06-18 Sale : show line 2 in the form −4,300 $37.75 $162,325 0 D
2018-06-18 Exercise or conversion : show line 3 in the form +2,700 $0.65 $1,755 2,700 D
2018-06-18 Sale : show line 4 in the form −2,700 $38.71 $104,517 0 D
2018-06-19 Exercise or conversion : show line 5 in the form +7,000 $11.21 $78,470 7,000 D
2018-06-19 Sale : show line 6 in the form −7,000 $38.39 $268,730 0 D
Open-market sales · 14,000 sh · avg $38.26 · $535,572

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2018-06-18 Exercise or conversion : show line 7 in the form Stock Option (right to buy) −7,000 104,307 D
2018-06-19 Exercise or conversion : show line 8 in the form Stock Option (right to buy) −7,000 83,897 D
Loading xslF345X03/edgar.xml…